Facial features of widespread neuroblastoma: A case report

International Journal of Paediatric Dentistry

Volumn 11, Issue 3, 2001, Pages 215-220

  Cliff, J F ^a   Newman, L ^a   Malone, M ^a   Brady, G ^b   Crean, St J ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DISEASE; ARTICLE; CANCER STAGING; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ECCHYMOSIS; FACE INJURY; FACE TUMOR; FOLLOW UP; HUMAN; MALE; METASTASIS; NEUROBLASTOMA; ORBIT DISEASE; PANCYTOPENIA; PRESCHOOL CHILD; VASCULAR TUMOR;

AORTIC DISEASES; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ECCHYMOSIS; FACIAL INJURIES; FACIAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; NEUROBLASTOMA; ORBITAL DISEASES; PANCYTOPENIA; VASCULAR NEOPLASMS;

EID: 0035348376     PISSN: 09607439     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-263X.2001.00269.x     Document Type: Article

References (14)

1. Ninane J, Pearson ADJ. Neuroblastoma. In: Pinkerton CR, Plowman PN, (eds) Paediatric Oncology, 2nd edn. London: Chapman & Hall, 1997: 443-483.
2. Brodeur GM, Castleberry RP. Neuroblastoma. In: Pizzo PA, Poplak DG. (eds) Principles and Practice of Paediatric Oncology, Philadelphia: J.B. Lippincott Co, 1997: 761-797.
3. Beckwith JB, Perrin EV. In situ neuroblastomas: a contribution to the natural history of neural crest tumours. American Journal of Pathology 1963; 43: 1089-1100.
4. Nakagawara A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Human Cell 1998; 11(3): 115-124.
5. Lukens JN. Neuroblastoma in the neonate. Seminars in Perinatology 1999; 23(4): 263-273.
6. Caron H, van Sluis P, de Kraker J et al. Allelic loss of chromosome 1p as a predictor of unfavourable outcome in patients with neuroblastoma. New England Journal of Medicine 1996; 334: 225-230.
7. Haase GM, Perez C, Atkinson JB. Current Aspects of biology, risk assessment and treatment of neuroblastoma. Seminars in Surgical Oncology 1999; 16: 91-104.
8. Brodeur GM, Pritchard J, Berthold F et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. Journal of Clinical Oncology 1993; 11: 1466-1477.
9. Zeltzer PM, Marangos PJ, Evans AE et al. Serum neurone-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Cancer 1986; 57: 1230-1234.
10. Berthold F, Trechow R, Utsch S, Zieschang J. Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases. American Journal of Pediatric Haematological Oncology 1992; 14(3): 207-215.
11. Philip T, Zucker JM, Bernard JL et al. Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup? Journal of Clinical Oncology 1991; 9(6): 1037-1044.
12. Matthay KK, O'Leary MC, Ramsay NK et al. Role of myeloablative therapy in improved outcome for high risk neuroblastoma: reviews of recent children's cancer group results. European Journal of Cancer 1995; 31A(4): 572-575.
13. Bohdiewicz PJ, Gallegos E, Fink-Bennett D. Raccoon eyes and the MIBG super scan: scintigraphic signs of neuroblastoma in a case of suspected child abuse. Pediatric Radiology 1995; 25(Suppl. 1): S90-S92.
14. Speight N. Bruises and burns: accidental or non accidental? In: Accidents and Emergencies in Childhood. London: Royal College of Physicians of London 1992: 97-103.